YOU ARE HERE:
Half of all new HIV infections could be averted if proven prevention efforts expanded
A new report suggests that 50% of projected HIV infections by 2015 could be prevented if governments and donors increase their HIV expenditure to UNAIDS target levels and implement prevention programmes that have been proven to work.
The Global HIV Prevention Working Group’s report, Bringing HIV Prevention to Scale: An Urgent Global Priority, shows that prevention efforts are not keeping pace with expanding access to antiretroviral therapy. For every person who started effective anti-HIV treatment in 2006, six become newly infected with the virus.
It is estimated that there will be 60 million new HIV infections by 2015, but the report suggests that 30 million of these could be avoided if scientifically proven methods of HIV prevention were implemented.
These measures include treatment to prevent mother-to-child transmission of HIV; testing; prevention efforts targeted at high risk groups, such as men who have sex with men and sex workers; and male circumcision.
However, the working group point to evidence showing that few people who would benefit from HIV prevention have access to it. This includes access to interventions that have been scientifically proven to significantly reduce the risk of HIV transmission, for example:
Although the report suggests that male circumcision could help reduce new HIV infections by 8% by 2015, it warns that no single prevention intervention can be 100% effective.
There has been a significant increase in global HIV spending in recent years, with projected spending in 2007 being $10 billion. However, the working group says that to make a real difference expenditure needs to more than double over the next three years to reach the UNAIDS target of $22 billion by 2010. Effective prevention would account for half of this money.
Membership of the working group includes public health experts, doctors, scientific researchers and people with HIV. It is jointly convened by the Henry J Kaiser Family Foundation and the Bill & Melinda Gates Foundation.
The Global HIV Prevention Working Group’s report, Bringing HIV Prevention to Scale: An Urgent Global Priority, shows that prevention efforts are not keeping pace with expanding access to antiretroviral therapy. For every person who started effective anti-HIV treatment in 2006, six become newly infected with the virus.
It is estimated that there will be 60 million new HIV infections by 2015, but the report suggests that 30 million of these could be avoided if scientifically proven methods of HIV prevention were implemented.
These measures include treatment to prevent mother-to-child transmission of HIV; testing; prevention efforts targeted at high risk groups, such as men who have sex with men and sex workers; and male circumcision.
However, the working group point to evidence showing that few people who would benefit from HIV prevention have access to it. This includes access to interventions that have been scientifically proven to significantly reduce the risk of HIV transmission, for example:
- Prevention of mother-to-child transmission – in low- and middle-income countries in 2005, only 11% of HIV-positive pregnant women had access to cheap treatment shown to dramatically reduce the risks of vertical transmission.
- HIV testing – only 12% of men and 10% of women in the African countries most seriously affected by HIV had had an HIV test.
- High-risk groups – prevention efforts reached only 9% of men who have sex with men, 8%of injecting drug users, and less than a fifth of sex workers in 2005. Many government still opt for general HIV awareness campaigns rather than initiatives targeted at the groups most at risk of infection.
Although the report suggests that male circumcision could help reduce new HIV infections by 8% by 2015, it warns that no single prevention intervention can be 100% effective.
There has been a significant increase in global HIV spending in recent years, with projected spending in 2007 being $10 billion. However, the working group says that to make a real difference expenditure needs to more than double over the next three years to reach the UNAIDS target of $22 billion by 2010. Effective prevention would account for half of this money.
Membership of the working group includes public health experts, doctors, scientific researchers and people with HIV. It is jointly convened by the Henry J Kaiser Family Foundation and the Bill & Melinda Gates Foundation.
aidsmap resources
Africa news
- Death rate in Malawi falls by up to 35% due to free HIV treatment
- Circumcision and partner reduction should be priorities for HIV prevention, say US researchers
- Counselling programme successfully promotes exclusive breast feeding in South Africa
Asia and Pacific news
- Clinical monitoring as effective as CD4 count and viral load for deciding when to switch to second-line ART in poor countries
- 8 million new HIV infections in Asia by 2020 unless prevention stepped up
- CD4 Select: an inexpensive, accurate new CD4 assay may benefit resource-limited settings
Developed world news
- BHIVA: Annual CD4 counts possible for stable patients, SMART analysis finds
- BHIVA: Concerns over confidentiality, drug interactions, communication, barriers to integrating GPs into HIV care
- Reckless HIV transmission case dismissed due to insufficient evidence (amended)
Eastern Europe and Russia news
- New drug users less likely to share needles, have HIV, in Russian study
- Estudo Russo revela mudança de comportamentos de risco entre os utilizadores de droga mais jovens
- Los nuevos usuarios de drogas son menos propensos a compartir agujas y tener VIH, según un estudio ruso
HIV and drug use news
- New drug users less likely to share needles, have HIV, in Russian study
- Most patients have a trusting relationship with their doctor after starting HIV drugs
- Daily cannabis use associated with worse fibrosis in patients with chronic hepatitis C
HIV and sexual health news
- Offer presumptive treatment for STIs to gay men testing HIV-positive
- High prevalence of cervical cancer-associated HPV strains in HIV-positive women in Uganda
- Abnormal anal cells and high-risk HPV common in HIV-positive Australians
Latin America news
- Some HIV subtypes may carry natural resistance to tipranavir
- 'Brazilian model' saves over $1 billion in anti-HIV treatment costs
- IAS: Roche admits long-standing low-level contamination of nelfinavir
